These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 22895395)

  • 1. Screening for pancreatic cancer: why, how, and who?
    Poruk KE; Firpo MA; Adler DG; Mulvihill SJ
    Ann Surg; 2013 Jan; 257(1):17-26. PubMed ID: 22895395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage inhibitory cytokine-1/growth differentiation factor-15 in premalignant and neoplastic tumours in a high-risk pancreatic cancer cohort.
    O'Neill RS; Emmanuel S; Williams D; Stoita A
    World J Gastroenterol; 2020 Apr; 26(14):1660-1673. PubMed ID: 32327914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for pancreatic cancer.
    Poruk KE; Firpo MA; Mulvihill SJ
    Adv Surg; 2014; 48():115-36. PubMed ID: 25293611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges in diagnosis of pancreatic cancer.
    Zhang L; Sanagapalli S; Stoita A
    World J Gastroenterol; 2018 May; 24(19):2047-2060. PubMed ID: 29785074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies for early detection of resectable pancreatic cancer.
    Okano K; Suzuki Y
    World J Gastroenterol; 2014 Aug; 20(32):11230-40. PubMed ID: 25170207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for pancreatic cancer in a high-risk population with serum CA 19-9 and targeted EUS: a feasibility study.
    Zubarik R; Gordon SR; Lidofsky SD; Anderson SR; Pipas JM; Badger G; Ganguly E; Vecchio J
    Gastrointest Endosc; 2011 Jul; 74(1):87-95. PubMed ID: 21704809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for pancreatic cancer: a review for general clinicians.
    Wiest NE; Moktan VP; Oman SP; Chirilă RM
    Rom J Intern Med; 2020 Sep; 58(3):119-128. PubMed ID: 32364522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early detection of pancreatic cancer: why, who, and how to screen.
    Klapman J; Malafa MP
    Cancer Control; 2008 Oct; 15(4):280-7. PubMed ID: 18813195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for pancreatic cancer in familial high-risk individuals: A systematic review.
    Lu C; Xu CF; Wan XY; Zhu HT; Yu CH; Li YM
    World J Gastroenterol; 2015 Jul; 21(28):8678-86. PubMed ID: 26229410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers for early diagnosis of pancreatic cancer.
    Jenkinson C; Earl J; Ghaneh P; Halloran C; Carrato A; Greenhalf W; Neoptolemos J; Costello E
    Expert Rev Gastroenterol Hepatol; 2015 Mar; 9(3):305-15. PubMed ID: 25373768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New strategies for the early detection of pancreatic cancer.
    Petrone MC; Arcidiacono PG
    Expert Rev Gastroenterol Hepatol; 2016; 10(2):157-9. PubMed ID: 26582179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining in Vitro Diagnostics with in Vivo Imaging for Earlier Detection of Pancreatic Ductal Adenocarcinoma: Challenges and Solutions.
    Laeseke PF; Chen R; Jeffrey RB; Brentnall TA; Willmann JK
    Radiology; 2015 Dec; 277(3):644-61. PubMed ID: 26599925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic cancer surveillance: learning as we go.
    Brentnall TA
    Am J Gastroenterol; 2011 May; 106(5):955-6. PubMed ID: 21540900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of endoscopic ultrasound in the screening and follow-up of high-risk individuals for familial pancreatic cancer.
    Lorenzo D; Rebours V; Maire F; Palazzo M; Gonzalez JM; Vullierme MP; Aubert A; Hammel P; Lévy P; de Mestier L
    World J Gastroenterol; 2019 Sep; 25(34):5082-5096. PubMed ID: 31558858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for Pancreatic Cancer in High-risk Populations.
    Grover S; Jajoo K
    Gastroenterol Clin North Am; 2016 Mar; 45(1):117-27. PubMed ID: 26895684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes.
    McGuigan A; Kelly P; Turkington RC; Jones C; Coleman HG; McCain RS
    World J Gastroenterol; 2018 Nov; 24(43):4846-4861. PubMed ID: 30487695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimation of the Survival Benefit Obtainable From Screening for the Early Detection of Pancreatic Cancer.
    Cucchetti A; Ercolani G; Cescon M; Brandi G; Taffurelli G; Maroni L; Ravaioli M; Pezzilli R; Pinna AD
    Pancreas; 2016; 45(5):714-9. PubMed ID: 26646274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycoprotein biomarkers for the detection of pancreatic ductal adenocarcinoma.
    Llop E; E Guerrero P; Duran A; Barrabés S; Massaguer A; José Ferri M; Albiol-Quer M; de Llorens R; Peracaula R
    World J Gastroenterol; 2018 Jun; 24(24):2537-2554. PubMed ID: 29962812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early detection of pancreatic cancer: Where are we now and where are we going?
    Zhou B; Xu JW; Cheng YG; Gao JY; Hu SY; Wang L; Zhan HX
    Int J Cancer; 2017 Jul; 141(2):231-241. PubMed ID: 28240774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Strategies for screening for pancreatic adenocarcinoma in high-risk patients: the place of endoscopic ultrasound].
    Béchade D
    Presse Med; 2011 Mar; 40(3):230-8. PubMed ID: 21211938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.